Document Detail


Risks and benefits of early antithrombotic therapy after thrombolytic treatment in patients with acute stroke.
MedLine Citation:
PMID:  23951093     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
BACKGROUND: Current guidelines recommend withholding antithrombotic therapy (ATT) for at least 24 h in patients with acute ischemic stroke treated with thrombolytic therapy. Herein, we report a retrospective analysis of a single-centre experience on the safety and efficacy of antithrombotic therapy (ATT) started before or after 24 h of intravenous thrombolysis in a cohort of acute ischemic stroke patients.
METHODS: A total of 139 patients (Rapid ATT group) received antithrombotic therapy before 24 h of thrombolysis, and 33 patients (Standard ATT group) after 24 h. The brain parenchyma and vessel status were assessed using simple CT scan on admission, multimodal CT scan at the end of thrombolysis, and angio-CT/MRI scan at day 3. Functional outcome was scored using the modified Rankin Scale (mRS) at day 90.
RESULTS: The two ATT groups had similar demographics, stroke subtypes, baseline NIHSS, thrombolytic strategies, vessel-patency rates at the end of thrombolysis, and incidence of bleeding complications at follow up. At day 3, the Rapid ATT group had a non-significant improved vessel-patency rate than the Standard ATT group. At day 90, a greater proportion of patients in the rapid ATT group had shifted down the mRS, and had improved in the NIHSS score.
CONCLUSIONS: ATT initiated before 24 h of intravenous thrombolytic therapy in acute stroke patients disclosed no safety concerns compared with a conventional antithrombotic therapy delay of 24 h and showed better functional outcome at follow up. The value of early initiation of ATT after thrombolysis deserves further assessment in randomized controlled trials.
Authors:
Sergio Amaro; Laura Llull; Xabier Urra; Víctor Obach; Alvaro Cervera; Angel Chamorro
Related Documents :
23279193 - Analgesic efficacy and safety of medical therapy alone vs combined medical therapy and ...
7326623 - Umbilical vein grafts for vascular access in patients on long-term dialysis.
21799173 - Efficacy and safety of combination antiplatelet therapies in patients with symptomatic ...
Publication Detail:
Type:  Journal Article     Date:  2013-08-08
Journal Detail:
Title:  PloS one     Volume:  8     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2013  
Date Detail:
Created Date:  2013-08-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e71132     Citation Subset:  IM    
Affiliation:
Functional Unit of Cerebrovascular Diseases, Hospital Clínic, Barcelona, Spain ; Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Inhibition of PPAR? Induces Cell Cycle Arrest and Apoptosis, and Synergizes with Glycolysis Inhibiti...
Next Document:  Hospital acquired pneumonia is linked to right hemispheric peri-insular stroke.